Reham mohamed
Asyut, Egypt
NCT Number: NCT06477341
note effect of appropriate nutrition on head and neck cancer patients receiving radiotherapy
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Asyut, Egypt
Head and neck cancer (HNC) is the sixth most common cancer worldwide with more than half a million new cases diagnosed each year . Because of the limitations imposed by the complicated anatomical structure of the head and neck to the operation, radiotherapy (RT) has become the main treatment method for HNC. However, damage to the normal tissue surrounding the tumor is inevitable. The most common manifestations of injury caused by RT are mucositis with the dry mouth, loss of taste, and dysphagia. The severe dysphagia leads to a definitive total impossibility of eating through the mouth in 20-30% of patients. Radiation-induced oral mucositis (RIOM) is a common side effect after radiotherapy (RT) in head and neck cancer (HNC) patients. RIOM patients with severe pain have difficulty in eating, which increases the incidence of malnutrition and affects patients' quality of life and the process of RT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
note effect with usually prescribed suitable oral and parenteral nutrition for head and neck cancers receiving radiotherapy
Time frame: two years
Follow up improvement by evaluating weight in kg and height in meters to calculate body mass index in kg / m^2
Assiut University
Other
The Effect of Active Nutritional Support On The Incidence Of Mucositis And Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03691714
Head and Neck Cancer, Head and Neck Neoplasms
Cincinnati, Ohio, United States
View Trial DetailsNCT05218824
Head and Neck Neoplasms, Neoplasms
Blacktown, New South Wales, Australia
View Trial DetailsNCT01235052
Cancer of Head and Neck, Head and Neck Neoplasms
Bordeaux, France
View Trial DetailsNCT03818061
Head and Neck Neoplasms, Neoplasms
Lyon, France
View Trial Details